All articles by GlobalData Healthcare

  1. Blood-brain barrier penetrating drug technology could be key to treating Alzheimer’s disease

    Alzheimer’s disease (AD) is a complex and poorly understood disorder that ultimately leads to neurodegeneration in patients afflicted with the…
    Read More…

    14 Nov
  2. Novartis’ Cosentyx sees mixed results from head-to-head with Humira

    On 1 November, Novartis reported the results of the Exceed trial, a Phase IIIb, double-blinded comparator trial of its interleukin…
    Read More…

    12 Nov
  3. FDA faces conundrum over future of AMAG’s Makena following drug withdrawal

    On 30 October, the US Food and Drug Administration’s (FDA) advisory committee (AdCom) voted in favour of withdrawing AMAG’s injectable…
    Read More…

    11 Nov
  4. Majority of Alzheimer’s disease clinical trials in the US parked in Phase I

    November in the US is Alzheimer’s Awareness Month, thanks to a 1983 decision by US President Ronald Reagan. Alzheimer’s disease…
    Read More…

    11 Nov
  5. Poseidon reaps success for AstraZeneca’s Imfinzi in non-small cell lung cancer

    Last week, AstraZeneca announced that its combination of Imfinzi (durvalumab) + chemotherapy, with or without tremelimumab, met its key endpoint…
    Read More…

    11 Nov
  6. AstraZeneca’s Flaura lung cancer results favour further first-line Tagrisso use

    AstraZeneca’s Tagrisso (osimertinib) is likely to see an uptick in uptake following final overall survival (OS) results from the Phase III…
    Read More…

    8 Nov
  7. Ayala plans Phase II cancer studies to start by first half of 2020

    Ayala Pharmaceuticals expects to initiate Phase II trials in triple-negative breast cancer (TNBC) and T-cell acute lymphoblastic lymphoma (T-ALL) with AL101…
    Read More…

    8 Nov
  8. 2018 was a top year for clinical trials for depression

    Depression is one of the most common mental disorders in the US. Many companies and organisations are continuing their research…
    Read More…

    1 Nov
  9. Benchmarking Phase II industry-sponsored pancreatic cancer trials

    Pancreatic cancer is rarely detected in its early stages, as it develops in the pancreas and spreads rapidly to other…
    Read More…

    1 Nov
  10. Top industry sponsors of checkpoint modulator trials

    GlobalData analysed the number of clinical trials examining checkpoint modulator trials with start dates between 1 January 2009 and 20…
    Read More…

    30 Oct
Close
Close
Close

Go Top